Scott Mullen, MBA Consultant

Scott is currently the commercial lead for connected healthcare projects at Ascendis Pharma. Prior to joining Ascendis, he was employed at Bayer as the brand lead for Betaseron (interferon beta-1b), where he led the U.S. launch of the BETACONNECT connected healthcare system. His prior work includes positions with prominent pharmaceutical companies such as Novo Nordisk, Merck, and Wyeth.

Now in his 29th year of working in the pharma industry, Scott brings a broad, cross-functional background to the connected healthcare field. His past roles include experience in pharma manufacturing (both solid dosage forms and sterile products), as well as roles in market research, medical education, field sales and brand marketing leadership.

Scott is an expert on managing the logistics and roll-out of connected healthcare systems, his current focus is on the utilization of patient-generated data in areas beyond the adherence monitoring role it has traditionally fulfilled. He holds a BSc in Biology and an MBA in Marketing, both from Syracuse University.